A dose-ranging exploratory study of the effects of ethyl-eicosapentaenoate in patients with persistent schizophrenic symptoms.

Source:http://linkedlifedata.com/resource/pubmed/id/11755456

Download in:

View as

Triples

General Info

PMID
11755456